280 related articles for article (PubMed ID: 18981410)
1. Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.
Strong JE; Wong G; Jones SE; Grolla A; Theriault S; Kobinger GP; Feldmann H
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17982-7. PubMed ID: 18981410
[TBL] [Abstract][Full Text] [Related]
2. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
3. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
[TBL] [Abstract][Full Text] [Related]
4. Review of Ebola virus infections in domestic animals.
Weingartl HM; Nfon C; Kobinger G
Dev Biol (Basel); 2013; 135():211-8. PubMed ID: 23689899
[TBL] [Abstract][Full Text] [Related]
5. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
Enterlein S; Warfield KL; Swenson DL; Stein DA; Smith JL; Gamble CS; Kroeker AD; Iversen PL; Bavari S; Mühlberger E
Antimicrob Agents Chemother; 2006 Mar; 50(3):984-93. PubMed ID: 16495261
[TBL] [Abstract][Full Text] [Related]
6. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
7. Dendritic Cells Generated From
Edenborough KM; Bokelmann M; Lander A; Couacy-Hymann E; Lechner J; Drechsel O; Renard BY; Radonić A; Feldmann H; Kurth A; Prescott J
Front Immunol; 2019; 10():2414. PubMed ID: 31681302
[TBL] [Abstract][Full Text] [Related]
8. NK Cells Accumulate in Infected Tissues and Contribute to Pathogenicity of Ebola Virus in Mice.
Fausther-Bovendo H; Qiu X; He S; Bello A; Audet J; Ippolito G; Wong G; Kobinger G
J Virol; 2019 May; 93(10):. PubMed ID: 30814283
[TBL] [Abstract][Full Text] [Related]
9. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.
Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS
J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682
[TBL] [Abstract][Full Text] [Related]
10. Ebola virus: unravelling pathogenesis to combat a deadly disease.
Hoenen T; Groseth A; Falzarano D; Feldmann H
Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and Persistence of Ebola Virus in Primary Cells from
Bokelmann M; Vogel U; Debeljak F; Düx A; Riesle-Sbarbaro S; Lander A; Wahlbrink A; Kromarek N; Neil S; Couacy-Hymann E; Prescott J; Kurth A
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834992
[TBL] [Abstract][Full Text] [Related]
12. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model.
Huggins J; Zhang ZX; Bray M
J Infect Dis; 1999 Feb; 179 Suppl 1():S240-7. PubMed ID: 9988190
[TBL] [Abstract][Full Text] [Related]
13. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
[TBL] [Abstract][Full Text] [Related]
14. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.
Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S941-6. PubMed ID: 21987773
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
[TBL] [Abstract][Full Text] [Related]
16. Dual beta-adrenergic modulation in the immune system: stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages.
Szelenyi J; Selmeczy Z; Brozik A; Medgyesi D; Magocsi M
Neurochem Int; 2006 Jul; 49(1):94-103. PubMed ID: 16515823
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.
Geisbert TW; Young HA; Jahrling PB; Davis KJ; Larsen T; Kagan E; Hensley LE
Am J Pathol; 2003 Dec; 163(6):2371-82. PubMed ID: 14633609
[TBL] [Abstract][Full Text] [Related]
18. Fruit bats as reservoirs of Ebola virus.
Leroy EM; Kumulungui B; Pourrut X; Rouquet P; Hassanin A; Yaba P; Délicat A; Paweska JT; Gonzalez JP; Swanepoel R
Nature; 2005 Dec; 438(7068):575-6. PubMed ID: 16319873
[TBL] [Abstract][Full Text] [Related]
19. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
Warfield KL; Swenson DL; Olinger GG; Nichols DK; Pratt WD; Blouch R; Stein DA; Aman MJ; Iversen PL; Bavari S
PLoS Pathog; 2006 Jan; 2(1):e1. PubMed ID: 16415982
[TBL] [Abstract][Full Text] [Related]
20. Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease.
Bird BH; Spengler JR; Chakrabarti AK; Khristova ML; Sealy TK; Coleman-McCray JD; Martin BE; Dodd KA; Goldsmith CS; Sanders J; Zaki SR; Nichol ST; Spiropoulou CF
J Infect Dis; 2016 Mar; 213(5):703-11. PubMed ID: 26582961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
